PBP2a substitutions linked to ceftaroline resistance in MRSA isolates from the UK

Ewan M. Harrison*, Xiaoliang Ba, Beth Blane, Matthew Ellington, Anette Loeffler, Robert Hill, Mark A. Holmes, Sharon J. Peacock

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)
Original languageEnglish
Pages (from-to)268-269
Number of pages2
JournalJournal of Antimicrobial Chemotherapy
Issue number1
Publication statusPublished - 1 Jan 2016

Bibliographical note

Funding Information:
This work was supported by UKCRC Translational Infection Research (TIR) Initiative, and the Medical Research Council (Grant Number G1000803) with contributions to the Grant from the Biotechnology and Biological Sciences Research Council, the National Institute for Health Research on behalf of the Department of Health, and the Chief Scientist Office of the Scottish Government Health Directorate and by a Medical Research Council Partnership grant (G1001787/1) held between the Department of Veterinary Medicine, University of Cambridge (M. A. H.), the School of Clinical Medicine, University of Cambridge (S. J. P.), the Moredun Research Institute and the Wellcome Trust Sanger Institute.

Cite this